デフォルト表紙
市場調査レポート
商品コード
1568043

人工心臓の世界市場

Artificial Hearts

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
適宜更新あり
人工心臓の世界市場
出版日: 2024年10月11日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

人工心臓の世界市場は2030年までに47億米ドルに到達

2023年に24億米ドルと推定される人工心臓の世界市場は、分析期間2023-2030年にCAGR 10.1％で成長し、2030年には47億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである左心室補助装置は、CAGR 9.8％を記録し、分析期間終了時には36億米ドルに達すると予測されます。全人工心臓セグメントの成長率は、分析期間でCAGR 12.7％と推定されます。

米国市場は6億5,870万米ドルと推定、中国はCAGR13.7％で成長予測

米国の人工心臓市場は、2023年に6億5,870万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけて13.7％のCAGRで成長し、2030年には9億9,980万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.5%と8.7%と予測されています。欧州では、ドイツがCAGR 7.9%で成長すると予測されています。

世界の人工心臓市場- 主要動向と促進要因のまとめ

人工心臓が心臓病分野に革命をもたらす理由とは？

人工心臓は心臓病学の分野で画期的なイノベーションとして登場し、従来の治療では不十分な末期心不全や重篤な心疾患に苦しむ患者に救命ソリューションを提供しています。しかし、人工心臓とは一体何なのでしょうか？そして、なぜ現代医療に不可欠なのでしょうか？従来の機械式心臓ポンプや補助人工心臓（VAD）は、機能不全に陥った心臓をサポートするために使用されますが、 完全人工心臓（TAH）は、心臓本来の機能を完全に代替するように設計されており、血液を全身に循環させるために両心室の仕事を引き継ぎます。これは、年齢や適切なドナーがいないこと、あるいは合併症のために従来の手術ができないなどの理由で心臓移植が不適格な患者にとって特に重要です。人間の心臓の機能を完全に再現することで、人工心臓は、移植への橋渡し、あるいは永久的な代替品としての役割を果たし、そうでなければ限られた選択肢しかない人々に希望を提供します。人工心臓の設計と応用は、生体適合性のある素材と高度なセンサーを取り入れることにより、血液凝固のリスクを減らし、血行動態の安定性を向上させるなど、当初から劇的な進化を遂げてきました。今日、人工心臓はもはや実験的なものとはみなされず、心臓外科医のツールキットにおける実行可能な選択肢とみなされ、患者の生存率とQOLを大幅に向上させています。

人工心臓開発を推進する主な技術革新とは？

人工心臓の開発は、これらの装置を初歩的な機械的ポンプから洗練された生命維持システムへと変化させる最先端技術と生物工学の進歩の合流によって推進されています。最も重要な技術革新のひとつは、バイオミメティック（生体模倣）設計の採用であり、人工心臓は、人間の心臓の自然な脈動流を再現するようにモデル化され、血栓症や溶血などの合併症のリスクを低減しています。このような設計は、高度な計算モデルと3Dプリンティング技術によって実現され、エンジニアは人工心臓の形状と機能を個々の患者の解剖学的構造に合うように微調整することができます。もう一つの重要な進歩は、スマートセンサーとリアルタイムのモニタリングシステムの統合で、これにより人工心臓は、身体活動時や休息時など、変化する身体のニーズに基づいて血流を自動的に調整することができます。この適応性は、健康な心臓と同様に生理的要求に確実に対応するために重要です。さらに、バッテリー技術の進歩は、人工心臓の寿命と携帯性を延ばし、頻繁な交換の必要性を減らし、患者の移動性を向上させています。ポリマーやチタン合金のような生体適合性材料の革新も、免疫反応を最小限に抑え、これらの装置の長期耐久性を向上させています。さらに、研究者たちは、ワイヤレス・エネルギー伝送や、外部コンポーネントを必要としない完全埋め込み型の人工心臓の使用を模索しており、それによって感染リスクを軽減しています。

人工心臓は、患者の予後とQOLをどのように向上させているのでしょうか？

人工心臓の登場は、患者の予後を劇的に改善し、重篤な心臓疾患により高い死亡率に直面していた人々に、新たな人生を提供します。心臓移植を待つ患者にとって、人工心臓は移植への重要な橋渡しとなり、適切なドナー臓器を待つ間、健康を安定させ、強化することができます。心臓移植が不可能な場合、人工心臓は永続的な解決策となり、患者は比較的普通の生活を送ることができます。全置換型人工心臓（TAH）のイントロダクションは、心臓の機能を完全に代行し、全身の血液循環と酸素供給をサポートすることができるため、特に大きな影響を及ぼしています。以前のものと比べ、最新の人工心臓は格段に小型化され、エネルギー効率もよく、使い勝手もよくなっているため、患者の自由度や移動性が向上しています。臨床データでは、人工心臓の使用により、ハイリスク患者の生存率が大幅に向上し、病院での再入院が減少し、長期的な健康状態の改善に貢献することが示されています。さらに、人工心臓は、血栓形成やデバイスの故障といった、以前のモデルで一般的であった合併症を最小限に抑えるように設計されています。これは、血球へのダメージを軽減する滑らかな表面や高度な抗凝固管理システムなど、綿密な設計改善によって達成されています。また、患者やその家族が、デバイスが身体のニーズに自律的に適応できることを知って不安を軽減し、安心感を向上させるという心理的な利点も注目に値します。こうした機器が進化し続けることで、心不全患者の寿命が延びるだけでなく、より質の高い生活が取り戻されることになります。

人工心臓市場の成長を促進する要因とは？

人工心臓市場の成長は、主に医療技術の進歩、心疾患の有病率の増加、ヘルスケア政策の進化に影響されるいくつかの要因によって牽引されています。主な要因の一つは、末期心不全やその他の重篤な心疾患の罹患率の上昇であり、世界人口の高齢化に伴い、代替治療オプションに対する緊急の需要が生じています。この動向は、ドナー心臓の慢性的な不足によって悪化しており、待機リストが数年に及ぶこともしばしばで、多くの患者は適切な臓器が利用できるようになる前に命を落としています。その結果、人工心臓は、移植までのつなぎとして、あるいは心臓移植の候補とならない患者の目的地療法として、ますます採用されるようになってきています。もう一つの重要な原動力は、生体工学と材料科学の技術革新が急速に進んでいることで、より耐久性が高く、生体適合性に優れ、効率的な人工心臓モデルの開発が進んでいます。このような技術的進歩により、人工心臓はより安全で利用しやすいものとなり、学術研究センターだけでなく、世界中の幅広いヘルスケア施設での利用が拡大しています。さらに、官民両部門による研究開発への投資拡大が、人工心臓の商業化と臨床採用を加速させています。さらに、ヘルスケア支出の増加や高度な心臓治療オプションに対する意識の高まりが、病院でのこれら最先端機器の採用を促し、市場の需要をさらに押し上げています。遠隔医療や遠隔モニタリング技術の拡大も、人工心臓の魅力を高めている要因の一つです。これらのソリューションにより、機器の性能や患者の健康状態をリアルタイムで追跡できるため、合併症が減少し、患者管理全体が改善されます。これらの促進要因が人工心臓市場の成長を後押しし、人工心臓を将来の心臓血管治療の重要な構成要素と位置づけ、重篤な心臓病患者の希望の光としています。

調査対象企業の例（注目の43社）

  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Artivion, Inc
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Calon Cardio-Technology Ltd.
  • CARMAT
  • Edwards Lifesciences Corporation
  • Jarvik Heart, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24104

Global Artificial Hearts Market to Reach US$4.7 Billion by 2030

The global market for Artificial Hearts estimated at US$2.4 Billion in the year 2023, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Left Ventricular Assist Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Total Artificial Heart segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$658.7 Million While China is Forecast to Grow at 13.7% CAGR

The Artificial Hearts market in the U.S. is estimated at US$658.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$999.8 Million by the year 2030 trailing a CAGR of 13.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Artificial Hearts Market - Key Trends and Drivers Summarized

Why Are Artificial Hearts Revolutionizing the Field of Cardiology?

Artificial hearts have emerged as a groundbreaking innovation in the field of cardiology, providing life-saving solutions for patients suffering from end-stage heart failure or severe cardiac conditions where conventional treatments are insufficient. But what exactly are artificial hearts, and why are they so critical to modern medicine? Unlike traditional mechanical heart pumps or ventricular assist devices (VADs), which are used to support a failing heart, total artificial hearts (TAHs) are designed to entirely replace the heart's natural function, taking over the job of both ventricles to circulate blood throughout the body. This is particularly important for patients who are ineligible for heart transplants due to age, lack of suitable donors, or complications that preclude traditional surgeries. By replicating the full functionality of a human heart, artificial hearts provide a bridge-to-transplant solution or serve as a permanent replacement, offering hope to those who would otherwise face limited options. The design and application of artificial hearts have evolved dramatically since their inception, incorporating biocompatible materials and advanced sensors to reduce clotting risks and improve hemodynamic stability. Today, artificial hearts are no longer considered experimental but are viewed as viable options in the toolkit of cardiac surgeons, significantly enhancing patient survival rates and quality of life.

What Are the Major Technological Innovations Driving Artificial Heart Development?

The development of artificial hearts is being propelled by a confluence of cutting-edge technologies and bioengineering advancements that are transforming these devices from rudimentary mechanical pumps into sophisticated, life-sustaining systems. One of the most significant innovations is the use of biomimetic designs, where artificial hearts are modeled to replicate the natural pulsatile flow of a human heart, reducing the risk of complications like thrombosis and hemolysis. These designs are achieved through the use of advanced computational models and 3D printing technologies, allowing engineers to fine-tune the shape and function of artificial hearts to match individual patient anatomies. Another pivotal advancement is the integration of smart sensors and real-time monitoring systems, which enable artificial hearts to automatically adjust blood flow based on the body’s changing needs, such as during physical activity or rest. This adaptability is critical for ensuring that the device can respond to physiological demands in a manner similar to a healthy heart. Additionally, progress in battery technology is extending the lifespan and portability of artificial hearts, reducing the need for frequent replacements and enhancing patient mobility. Innovations in biocompatible materials, such as polymers and titanium alloys, are also minimizing immune responses and improving the long-term durability of these devices. Furthermore, researchers are exploring the use of wireless energy transfer and fully implantable artificial hearts that eliminate the need for external components, thereby reducing infection risks.

How Are Artificial Hearts Enhancing Patient Outcomes and Quality of Life?

The advent of artificial hearts is dramatically enhancing patient outcomes, providing a new lease on life for individuals who would otherwise face high mortality rates due to severe cardiac conditions. For patients awaiting heart transplants, artificial hearts offer a crucial bridge-to-transplant option, allowing them to stabilize and strengthen their health while waiting for a suitable donor organ. In cases where a heart transplant is not feasible, artificial hearts can serve as a permanent solution, enabling patients to lead relatively normal lives. The introduction of total artificial hearts (TAHs) has been particularly impactful, as these devices can completely take over cardiac function, supporting blood circulation and oxygenation throughout the body. Compared to earlier iterations, modern artificial hearts are significantly more compact, energy-efficient, and user-friendly, allowing patients greater freedom and mobility. Clinical data has shown that the use of artificial hearts can significantly improve survival rates in high-risk patients and reduce hospital readmissions, contributing to better long-term health outcomes. Additionally, artificial hearts are engineered to minimize complications such as blood clot formation and device failure, which were common issues in earlier models. This is achieved through meticulous design improvements, including smoother surfaces to reduce blood cell damage and advanced anticoagulation management systems. Psychological benefits are also notable, as patients and their families experience reduced anxiety and an improved sense of security knowing that the device is capable of autonomously adapting to the body’s needs. As these devices continue to evolve, they are not only extending life expectancy for heart failure patients but also restoring a higher quality of life.

What Factors Are Driving the Growth of the Artificial Hearts Market?

The growth in the artificial hearts market is driven by several factors, primarily influenced by advancements in medical technology, a growing prevalence of heart disease, and evolving healthcare policies. One of the main drivers is the rising incidence of end-stage heart failure and other severe cardiac conditions, which are creating an urgent demand for alternative treatment options as the global population ages. This trend is exacerbated by the chronic shortage of donor hearts, with waiting lists often spanning years and many patients succumbing before a suitable organ becomes available. As a result, artificial hearts are being increasingly adopted as either a bridge-to-transplant solution or as a destination therapy for patients who are not candidates for heart transplantation. Another critical driver is the rapid pace of innovation in bioengineering and material science, which is leading to the development of more durable, biocompatible, and efficient artificial heart models. These technological advancements are making artificial hearts safer and more accessible, thereby expanding their use beyond academic research centers to a broader range of healthcare facilities worldwide. Moreover, growing investments in research and development by both public and private sectors are accelerating the commercialization and clinical adoption of artificial hearts. Additionally, increased healthcare expenditure and rising awareness about advanced cardiac care options are encouraging hospitals to adopt these cutting-edge devices, further boosting market demand. The expansion of telemedicine and remote monitoring technologies is another factor enhancing the appeal of artificial hearts, as these solutions enable real-time tracking of device performance and patient health, reducing complications and improving overall patient management. Collectively, these drivers are propelling the growth of the artificial hearts market, positioning it as a critical component of the future of cardiovascular care and a beacon of hope for patients with severe cardiac ailments.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Artivion, Inc
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Calon Cardio-Technology Ltd.
  • CARMAT
  • Edwards Lifesciences Corporation
  • Jarvik Heart, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Artificial Hearts - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Failure Drives Demand for Advanced Artificial Heart Solutions
    • Here's the Story: How the Shortage of Donor Hearts Expands the Addressable Market for Artificial Hearts
    • Increasing Adoption of Artificial Hearts as Bridge-to-Transplant Options Propels Market Growth
    • Advancements in Biomaterials and Sensor Integration Strengthen Business Case for Next-Generation Artificial Hearts
    • Rising Geriatric Population Spurs Demand for Long-Term Artificial Heart Implants
    • Here's How Improvements in Battery Technology Generate Opportunities for Portable Artificial Hearts
    • Expansion of Minimally Invasive Surgical Techniques Drives Adoption of Compact and Efficient Artificial Heart Devices
    • Emphasis on Reducing Complications Sustains Growth in the Development of Thrombosis-Resistant Artificial Hearts
    • Focus on Patient-Specific Customization Creates New Growth Opportunities for Personalized Artificial Heart Devices
    • High Costs of Artificial Hearts Pose Challenges to Widespread Adoption in Cost-Sensitive Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Hearts Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Hearts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Left Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Left Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Left Ventricular Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Total Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Total Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Total Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Heart-Lung Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Heart-Lung Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Heart-Lung Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • JAPAN
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • CHINA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • EUROPE
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Artificial Hearts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • FRANCE
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • GERMANY
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Artificial Hearts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • INDIA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Artificial Hearts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Artificial Hearts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • AFRICA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030

IV. COMPETITION